Research

21 results.

March 29, 2022 How do molecular ‘switches’ impact colorectal cancer? And what could they mean for treatment?

Throughout our lives, we’ve been reminded that eating a nutritious diet is important for our overall good health and helps reduce the risk of many…

October 20, 2021 Meet the scientist behind the science: Dr. Scott Rothbart

Earlier today, we announced that Van Andel Institute Associate Professor Dr. Scott Rothbart has been awarded a Research Scholar Grant from…

October 20, 2021 American Cancer Society grant to support Van Andel Institute research into anti-cancer medications

GRAND RAPIDS, Mich. (Oct. 20, 2021) — Van Andel Institute’s Scott Rothbart, Ph.D., has earned a four-year, $792,000 Research…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer

The Coriell Institute for Medical Research and…

August 18, 2021 Van Andel Institute earns prestigious grant to train postdoctoral fellows in cancer epigenetics

GRAND RAPIDS, Mich. (Aug. 18, 2021) — The National Cancer Institute has awarded Van Andel Institute a five-year, $1.7 million grant to establish a…

November 20, 2020 After more than a decade, ChIP-seq may be quantitative after all

GRAND RAPIDS, Mich. (Nov. 20, 2020) — For more than a decade, scientists studying epigenetics have used a powerful method called ChIP-seq to map changes…

April 4, 2019 Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…

November 28, 2018 High-throughput platform enables scientists to map activity of an emerging class of cancer drug targets

GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for…